OVID Ovid Therapeutics Inc.

$2.77 +2.03%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Ovid Therapeutics Inc. (OVID) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $541 million. Shares last traded at $2.77, 10.8% below their 52-week high. Over the past year the stock is up 108.3%. Net profit margin is -475.6%, below the peer median of -8.9%. Revenue declined 96.8% year over year.

Market Cap

$541M

Shares Out

195.3M

EPS (TTM)

$-0.97

P/E Ratio

—

P/S Ratio

74.60

P/B Ratio

2.58

Dividend / Share

—

Dividend Yield

—

52-Week High

$3.10

52-Week Low

$1.13

Volume

156,935

Avg Vol (3m)

150,737.429

Performance

-5.14%

+2.97%

+12.15%

+50.14%

YTD

+57.83%

+108.27%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

52.73

SMA (50)

$2.61

SMA (200)

$2.19

Price vs SMA50

+6.23%

Price vs SMA200

+26.45%

ATR (14)

$0.14

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$7M

Net Income

$-34M

Gross Margin

—

Operating Margin

-804.7%

Net Margin

-475.6%

Return on Equity

-16.4%

Return on Assets

-14.9%

Current Ratio

12.39

Debt / Equity

0.11

Revenue Growth (YoY)

-96.8%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q3 2024	$-0.24	2024-11-12
Q2 2024	$-0.04	2024-08-13
Q1 2024	$-0.17	2024-05-14
FY 2023	$-0.74	2024-03-08
Q3 2024	$-0.52	2024-11-12
Q2 2024	$-0.37	2024-08-13

Full earnings history →

Pharmaceutical Preparations peers

OVID vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/S vs peers

74.60 / 11.11 med

+572% premium

Net margin vs peers

-475.6% / -8.9% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.